89 related articles for article (PubMed ID: 27815022)
1. The σ1 receptor regulates accumulation of GM1 ganglioside-enriched autophagosomes in astrocytes.
Kasahara R; Yamamoto N; Suzuki K; Sobue K
Neuroscience; 2017 Jan; 340():176-187. PubMed ID: 27815022
[TBL] [Abstract][Full Text] [Related]
2. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
Reuss B; Unsicker K
Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180
[TBL] [Abstract][Full Text] [Related]
3. Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover.
Vital MA; Flório JC; Frussa-Filho R; De Lucia R; Tufik S; Palermo-Neto J
Life Sci; 1998; 62(13):1161-9. PubMed ID: 9519797
[TBL] [Abstract][Full Text] [Related]
4. A feasibility study of [11C]SA4503-PET for evaluating sigmal receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D2-like receptors.
Ishiwata K; Oda K; Sakata M; Kimura Y; Kawamura K; Oda K; Sasaki T; Naganawa M; Chihara K; Okubo Y; Ishii K
Ann Nucl Med; 2006 Oct; 20(8):569-73. PubMed ID: 17134027
[TBL] [Abstract][Full Text] [Related]
5. Astrocytes in cell culture incorporate GM1 ganglioside.
Masco D; Flott B; Seifert W
Glia; 1989; 2(4):231-40. PubMed ID: 2548962
[TBL] [Abstract][Full Text] [Related]
6. Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain.
Mahadik SP; Mukherjee S
Biol Psychiatry; 1995 Aug; 38(4):246-54. PubMed ID: 8547447
[TBL] [Abstract][Full Text] [Related]
7. Involvement of sigma-1 receptor in astrocyte activation induced by methamphetamine via up-regulation of its own expression.
Zhang Y; Lv X; Bai Y; Zhu X; Wu X; Chao J; Duan M; Buch S; Chen L; Yao H
J Neuroinflammation; 2015 Feb; 12():29. PubMed ID: 25889537
[TBL] [Abstract][Full Text] [Related]
8. GM1 ganglioside administration partially counteracts the morphological changes associated with haloperidol treatment within the dorsal striatum of the rat.
Meshul CK; Stallbaumer RK; Allen C
Psychopharmacology (Berl); 1995 Oct; 121(4):461-9. PubMed ID: 8619009
[TBL] [Abstract][Full Text] [Related]
9. Failure of plasma membranes of astrocytes in primary culture to insert exogenous ganglioside GM1.
Asou H; Brunngraber EG
Neurosci Lett; 1984 Apr; 46(1):115-8. PubMed ID: 6374517
[TBL] [Abstract][Full Text] [Related]
10. Binding of cholera toxin B subunit: a surface marker for murine microglia but not oligodendrocytes or astrocytes.
Nedelkoska L; Benjamins JA
J Neurosci Res; 1998 Sep; 53(5):605-12. PubMed ID: 9726431
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of GM1 effects on haloperidol-induced dopaminergic supersensitivity.
Palermo-Neto J; Frussa-Filho R; Vital MA
Gen Pharmacol; 1999 Feb; 32(2):265-70. PubMed ID: 10188630
[TBL] [Abstract][Full Text] [Related]
12. Haloperidol Affects Plasticity of Differentiated NG-108 Cells Through σ1R/IP
Kubickova J; Lencesova L; Csaderova L; Stracina T; Hudecova S; Babula P; Rozborilova E; Novakova M; Krizanova O
Cell Mol Neurobiol; 2018 Jan; 38(1):181-194. PubMed ID: 28786032
[TBL] [Abstract][Full Text] [Related]
13. Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding.
Schröder U; Schröder H; Augustin W; Sabel BA
J Pharmacol Exp Ther; 1994 Dec; 271(3):1193-6. PubMed ID: 7996425
[TBL] [Abstract][Full Text] [Related]
14. Disruption of dopamine D1/D2 receptor complex is involved in the function of haloperidol in cardiac H9c2 cells.
Lencesova L; Szadvari I; Babula P; Kubickova J; Chovancova B; Lopusna K; Rezuchova I; Novakova Z; Krizanova O; Novakova M
Life Sci; 2017 Dec; 191():186-194. PubMed ID: 29054453
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptics with differential affinities at dopamine D2 receptors and sigma receptors affect differently the N-methyl-D-aspartate-induced increase in intracellular calcium concentration: involvement of protein kinase.
Hayashi T; Su TP; Kagaya A; Nishida A; Shimizu M; Yamawaki S
Synapse; 1999 Jan; 31(1):20-8. PubMed ID: 10025680
[TBL] [Abstract][Full Text] [Related]
16. Activation of the sigma-1 receptor by haloperidol metabolites facilitates brain-derived neurotrophic factor secretion from human astroglia.
Dalwadi DA; Kim S; Schetz JA
Neurochem Int; 2017 May; 105():21-31. PubMed ID: 28188803
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
Lidow MS; Goldman-Rakic PS
J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
[TBL] [Abstract][Full Text] [Related]
18. Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons.
Li A; Guo H; Luo X; Sheng J; Yang S; Yin Y; Zhou J; Zhou J
FASEB J; 2006 Jun; 20(8):1263-5. PubMed ID: 16636101
[TBL] [Abstract][Full Text] [Related]
19. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
Pope-Coleman A; Tinker JP; Schneider JS
Synapse; 2000 May; 36(2):120-8. PubMed ID: 10767059
[TBL] [Abstract][Full Text] [Related]
20. Absence of ganglioside GM1 in astroglial cells from 21-day old rat brain: immunohistochemical, histochemical, and biochemical studies.
Asou H; Brunngraber EG
Neurochem Res; 1983 Aug; 8(8):1045-57. PubMed ID: 6194443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
